 | Up a level |
Faou, M., Lemay, A., Decary-Hetu, D., Calvet, J., Labreche, F., Jean, M., Dupont, B., & Fernandez, J. M. (2016, December). Follow the traffic: Stopping click fraud by disrupting the value chain [Paper]. 14th Annual Conference on Privacy, Security and Trust (PST 2016), Auckland, New Zealand. External link
Merzouki, A., Buschmann, M. D., Jean, M., Young, R. S., Liao, S., Gal, S., Li, Z. M., & Slilaty, S. N. (2012). Adva-27a, a Novel Podophyllotoxin Derivative Found to Be Effective Against Multidrug Resistant Human Cancer Cells. Anticancer Research, 32(10), 4423-4432. External link
Alameh, M., DeJesus, D., Benhamadi, M., Jean, M., Buschmann, M. D., & Merzouki, A. (2011, May). Chitosan nanoparticulate system for the delivery of siRNA targeting genome caretakers for the development of potential cancer therapies [Paper]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec. Unavailable
Jean, M., Alamech, M., Buschmann, M. D., & Merzouki, A. (2011). Effective and safe gene-based delivery of GLP using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of diabetes. Gene Therapy, 18(8), 807-816. External link
Jean, M., Alameh, M., Daras, V., Lavertu, M., Thibault, M., Buschmann, M. D., & Merzouki, A. (2011, May). Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of Type 2 Diabetes [Paper]. 14th Annual Meeting American Society of Gene and Cell Therapy, Seattle, WA, USA. Unavailable
Jean, M., Alameh, M., Daras, V., Lavertu, M., Thibault, M., Buschmann, M. D., & Merzouki, A. (2011, May). Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of Type 2 Diabetes [Paper]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec, Canada. Unavailable
DeJesus, D., Alameh, M., Jean, M., Lascau, V., Buschmann, M. D., & Merzouki, A. (2011, May). Therapeutic lowering of circulating ApoB in atherosclerotic mice by intravenous administration of chitosan-siRNA nanoparticles [Paper]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec. Unavailable
Alamech, M., Jean, M., DeJesus, D., Buschmann, M. D., & Merzouki, A. (2010). Chitosanase-based method for RNA isolation from cells transfected with chitosan/siRNA nanocomplexes for real-time RT-PCR in gene silencing. International Journal of Nanomedicine, 5, 473-481. External link
Buschmann, M. D., Thibault, M., Merzouki, A., Lavertu, M., Ma, P. L., Jean, M., Darras, V., & Winnik, F. M. (2010, May). Polynucleotide delivery with chitosans [Paper]. 93rd Canadian Chemistry Conference, Toronto, Ontario. Unavailable
Jean, M., Smaoui, F., Lavertu, M., Methot, S., Bouhdoud, L., Buschmann, M. D., & Merzouki, A. (2009). Chitosan-Plasmid Nanoparticle Formulations for Im and Sc Delivery of Recombinant Fgf-2 and Pdgf-Bb or Generation of Antibodies. Gene Therapy, 16(9), 1097-1110. External link
Méthot, S., Lavertu, M., Sun, J., Smaoui, F., Jean, M., Merzouki, A., & Buschmann, M. D. (2007, September). Efficient in vivo gene delivery using chitosan/DNA nanoparticles for applications in cartilage repair [Paper]. 7th World Congress International Society for Cartilage Repair, Warsaw, Poland. External link
Smaoui, F., Buschmann, M. D., Jean, M., Bouhdoud, L., Henrichon, M., Méthot, S., & Merzouki, A. (2006, June). The chitosan used as a delivery system of therapeutic growth factors for the induction of cartilage regeneration [Paper]. Canadian Society of Microbiologists Annual Conference, London, Ontario. Unavailable
